Projects per year
Fingerprint
Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
STAT3 inhibition as a therapeutic strategy against MDS stem cells
Verma, A. K., Steidl, U. G., Steidl, U. U. & Verma, A. K.
National Heart, Lung, and Blood Institute
7/23/19 → 6/30/23
Project: Research project
-
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
1/1/19 → 6/30/20
Project: Research project
-
-
Therapeutic targeting of MDS stem cells
Verma, A. K., Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/22
Project: Research project
-
-
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
Choudhary, G. S., Pellagatti, A., Agianian, B., Smith, M. A., Bhagat, T. D., Gordon-Mitchell, S., Sahu, S., Pandey, S., Shah, N., Aluri, S., Aggarwal, R., Aminov, S., Schwartz, L., Steeples, V., Booher, R. N., Ramachandra, M., Samson, M., Carbajal, M., Pradhan, K., Bowman, T. V., & 11 others, Aug 30 2022, In: eLife. 11Research output: Contribution to journal › Article › peer-review
Open Access -
A needed boost against COVID-19 in lymphoma
Fromowitz, A. & Verma, A., May 2022, In: Nature Cancer. 3, 5, p. 526-527 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
Sekeres, M. A., Schuster, M., Joris, M., Krauter, J., Maertens, J., Breems, D., Gyan, E., Kovacsovics, T., Verma, A., Vyas, P., Wang, E. S., Ching, K., O’Brien, T., Gallo Stampino, C., Ma, W. W., Kudla, A., Chan, G. & Zeidan, A. M., Aug 2022, In: Annals of Hematology. 101, 8, p. 1689-1701 13 p.Research output: Contribution to journal › Article › peer-review
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Jan 8 2022, In: The Lancet. 399, 10320, p. 143-151 9 p.Research output: Contribution to journal › Article › peer-review
Open Access67 Scopus citations -
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Gerds, A. T., Scott, B. L., Greenberg, P., Lin, T. L., Pollyea, D. A., Verma, A., Dail, M., Feng, Y., Green, C., Ma, C., Medeiros, B. C., Yan, M., Yousefi, K. & Donnellan, W., Feb 22 2022, In: Blood Advances. 6, 4, p. 1152-1161 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations